Case File
efta-efta00920935DOJ Data Set 9OtherFrom: Jeffrey Epstein <jeevacation@gmail.com>
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00920935
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey Epstein <jeevacation@gmail.com>
To: Ssulayem
Subject:
Date: Sat, 24 Sep 2011 19:11:56 +0000
•
Open Folder
• g',Inbox
Inbox
• g:&npty Trash
Empty Trash
• ;New Message
New Message
• g'Folders
Folders
•
iSearch
Search
• ; °,'Address Book
Address Book
• Qptions
Lions
•
P
Help
• 21,sog out
Log out
Quota status: 212.31MB / 1000.00MB (21.23%)
Inbox: clomid (873 of 873) gjPersonalgiUnseen
Move I Copy
Back to Inbox
Delete I Reply I Forward I Redirect I View Thread I Message Source I Save as I Print I Report as Spam
Sat, 24 Sep 2011 14:55:02 EDT [14:55:02 EDT]
From:
Manny
Address Book
To:
anny
Address Book
Subject: clomid
Part(s):
2 MillenniumSciencesIPSept2011-Final.docx [application/octet-stream] 2D AB ;2Download
Download All Attachments (in .zip fileJjDownload All Attachments (in .zip file)
Headers: Show All Headers
1 unnamed [text/html] 3.22 KB
Download
Alternative parts for this section: H
gjMultipart/altemative
unnamed [text/plain] 2.76 KB ;Download
--1-1TML Click HERE to view HTML content in a separate window.
Richard, look at the attachment which describes my patents and the field. Also. below is a blog I wrote.
---Harry
EFTA00920935
Increasing a Man's Testosterone Production
The problems caused by abnormally low testosterone — a condition called hypogonadism — have been getting a lot of press
in recent years, primarily because there are now several companies selling testosterone replacement products. Low
testosterone, or tow T," can certainly be a real problem for men. The issue with trying to coifed low testosterone levels by
adding extra testosterone is that the body responds by shutting down its own testosterone-making machinery. That means
the testicles shrink and soften and, if you stop taking the replacement therapy, your testosterone levels will drop even lower
than they were before you started. It's easy to get hooked, in other words.
Another approach for treating low testosteroneis to stimulate the body's own capacity to make testosterone — to fortify the
testicles. Clomiphene citrate, marketed in pill form as Cbmid or Serophene, is a prescription medicine commonly used for
female infertility. It works by stimulating a part of the brain (the pituitary gland) that controls production of two hormones key
to reproductive health: follicle stimulating hormone (FSH) and luteinizing hormone (LH). Both hormones are also vital to men.
FSH stimulates sperm production in the testicles, and LH stimulates testosterone production.
A number of studies have now conclusively demonstrated that modest doses of clomiphene successfully raises testosterone
levels in men without impairing testicular function. Not only is testosterone boosted, sperm production and sperm quality may
be enhanced as well.
I believe using cbmiphene is an excellent way to raise the body's testosterone levels — particularly in men using it to treat
infertility. Other drugs similar to clomiphene are being developed that may provide similar benefits with, perhaps, lower risks
(though cbmiphene is, relatively speaking, a very safe drug). Future research may provide a new generation of medications
to safely and effectively increase testosterone levels without the need for direct testosterone replacement therapy.
A word of caution: cbmiphene should only be used under a doctor's supervision, and it should only be used by men who
have documented hypogonadism. Like any medicine, cbmiphene can be abused, and if not used correctly in appropriate
patients, it may do more harm than good.
Delete I Reply I Forward I Redirect I View Thread I Message Source I Save as I Print I Report as Spam
Move I Copy
Back to Inbox
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacation@gmail.com, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00920936
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
jeevacation@gmail.comRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
OtherUnknown
FEDWIRE PAYMENT DEBIT ADVICE
DOJ EFTA Data Set 10 document EFTA01273102
16p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.